
Guarding the Jaw: LOXL2 Enzyme Shows Promise Against TMJ Arthritis
Researchers identify LOXL2 as a protector of jaw cartilage in TMJ osteoarthritis. LOXL2 helps suppress the NF-κB inflammatory pathway, preserves chondrocyte viability, and maintains cartilage matrix. Loss of LOXL2 activates inflammatory genes and accelerates cartilage breakdown; boosting LOXL2 reduced inflammatory markers and protected cartilage in mouse and goat tissues, suggesting LOXL2 as a potential therapeutic target for TMJ disorders, though human studies and approved TMJ-specific treatments are still needed.





